---
figid: PMC4491676__cancers-07-00648-g003
figlink: /pmc/articles/PMC4491676/figure/cancers-07-00648-f003/
number: Figure 3
caption: PP2A as a promoter of carcinogenesis. The PP2A holoenzymes containing B55α
  and B55δ play a positive regulatory role in the MAP kinase pathway through direct
  dephosphorylation of RAF1 on Ser259. The PP2A holoenzyme containing B55α also dephophorylates
  KSR1 on Ser392 and RAF on Ser295 to activate ERK [,]. Inhibition of PP2A by Cantharidin
  promotes apoptosis in cancer cells by mediating the prolonged phosphorylation of
  I κ B kinase α (IKK) and activation of NFκB []. Cantharidin also induces apoptosis
  by blocking PP2A mediated activation of the MAP kinase pathway [,]. Inhibition of
  PP2A using okadaic acid increases the sensitivity of breast cancer cells to the
  drug lapatinib which has an anti-proliferative effect on cells [].
pmcid: PMC4491676
papertitle: 'PP2A: The Wolf in Sheep’s Clothing?.'
reftext: Maeve Kiely, et al. Cancers (Basel). 2015 Jun;7(2):648-669.
pmc_ranked_result_index: '4445'
pathway_score: 0.9227269
filename: cancers-07-00648-g003.jpg
figtitle: PP2A as a promoter of carcinogenesis
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4491676__cancers-07-00648-g003.html
  '@type': Dataset
  description: PP2A as a promoter of carcinogenesis. The PP2A holoenzymes containing
    B55α and B55δ play a positive regulatory role in the MAP kinase pathway through
    direct dephosphorylation of RAF1 on Ser259. The PP2A holoenzyme containing B55α
    also dephophorylates KSR1 on Ser392 and RAF on Ser295 to activate ERK [,]. Inhibition
    of PP2A by Cantharidin promotes apoptosis in cancer cells by mediating the prolonged
    phosphorylation of I κ B kinase α (IKK) and activation of NFκB []. Cantharidin
    also induces apoptosis by blocking PP2A mediated activation of the MAP kinase
    pathway [,]. Inhibition of PP2A using okadaic acid increases the sensitivity of
    breast cancer cells to the drug lapatinib which has an anti-proliferative effect
    on cells [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K2
  - MAP2K1
  - KRAS
  - NRAS
  - IKBKB
  - MAPK1
  - HRAS
  - REL
  - MINK1
  - NFKB1
  - NFKB2
  - IKBKG
  - MAPK8
  - MAPK14
  - MAPK11
  - RAF1
  - MAPK3
  - MAPK9
  - MAPK10
  - RELB
  - ARAF
  - CHUK
  - RELA
  - BRAF
  - MAPK12
  - MAPK13
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: B55
  symbol: B55
  source: hgnc_alias_symbol
  hgnc_symbol: MINK1
  entrez: '50488'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
